FDA to commence up naming names of pharma companies blocking off more cost effective generics
Enlarge / Dr. Scott Gottlieb, commissioner of the Food and Drug Administration, ready to name and shame. The Food and Drug Administration plans this week to effectively begin publicly shaming brand-name drug companies that stand in the way of competitors trying to develop cheaper generic drugs. FDA Commissioner Scott Gottlieb told reporters on Monday and…

Commentaires récents